BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17363841)

  • 1. Absence of full-length Brca1 sensitizes mice to oxidative stress and carcinogen-induced tumorigenesis in the esophagus and forestomach.
    Cao L; Xu X; Cao LL; Wang RH; Coumoul X; Kim SS; Deng CX
    Carcinogenesis; 2007 Jul; 28(7):1401-7. PubMed ID: 17363841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency.
    Cao L; Kim S; Xiao C; Wang RH; Coumoul X; Wang X; Li WM; Xu XL; De Soto JA; Takai H; Mai S; Elledge SJ; Motoyama N; Deng CX
    EMBO J; 2006 May; 25(10):2167-77. PubMed ID: 16675955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice.
    Fong LY; Ishii H; Nguyen VT; Vecchione A; Farber JL; Croce CM; Huebner K
    Cancer Res; 2003 Jan; 63(1):186-95. PubMed ID: 12517797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis.
    Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX
    Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploinsufficiency of Parp1 accelerates Brca1-associated centrosome amplification, telomere shortening, genetic instability, apoptosis, and embryonic lethality.
    Wang X; Liu L; Montagna C; Ried T; Deng CX
    Cell Death Differ; 2007 May; 14(5):924-31. PubMed ID: 17318223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal lymphocyte development and thymic lymphoma formation in Brca1 exon-11-deficient mice.
    Bachelier R; Xu X; Wang X; Li W; Naramura M; Gu H; Deng CX
    Oncogene; 2003 Jan; 22(4):528-37. PubMed ID: 12555066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of BRCA1 Spontaneously Induces the Tumorigenesis in Lacrimal Gland.
    Kim SE; Baek HJ; Park EJ; Lim SC; Kim SS
    Anal Cell Pathol (Amst); 2018; 2018():8120579. PubMed ID: 30652068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterus hyperplasia and increased carcinogen-induced tumorigenesis in mice carrying a targeted mutation of the Chk2 phosphorylation site in Brca1.
    Kim SS; Cao L; Li C; Xu X; Huber LJ; Chodosh LA; Deng CX
    Mol Cell Biol; 2004 Nov; 24(21):9498-507. PubMed ID: 15485917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined cyclin D1 overexpression and zinc deficiency disrupts cell cycle and accelerates mouse forestomach carcinogenesis.
    Fong LY; Mancini R; Nakagawa H; Rustgi AK; Huebner K
    Cancer Res; 2003 Jul; 63(14):4244-52. PubMed ID: 12874033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated susceptibility of the p53 knockout mouse esophagus to methyl-N-amylnitrosamine carcinogenesis.
    Shirai N; Tsukamoto T; Yamamoto M; Iidaka T; Sakai H; Yanai T; Masegi T; Donehower LA; Tatematsu M
    Carcinogenesis; 2002 Sep; 23(9):1541-7. PubMed ID: 12189199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperplasia and spontaneous tumor development in the gynecologic system in mice lacking the BRCA1-Delta11 isoform.
    Kim SS; Cao L; Lim SC; Li C; Wang RH; Xu X; Bachelier R; Deng CX
    Mol Cell Biol; 2006 Sep; 26(18):6983-92. PubMed ID: 16943438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral transduction of splice variant Brca1-Delta11 or mutant Brca1-W1777Stop causes mouse epithelial mammary atypical duct hyperplasia.
    Bachelier R; Vincent A; Mathevet P; Magdinier F; Lenoir GM; Frappart L
    Virchows Arch; 2002 Mar; 440(3):261-6. PubMed ID: 11889595
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    He Y; Rivera J; Diossy M; Duan H; Bowman-Colin C; Reed R; Jennings R; Novak J; Tran SV; Cohen EF; Szuts D; Giobbie-Hurder A; Bronson RT; Bass AJ; Signoretti S; Szallasi Z; Livingston DM; Pathania S
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34607954
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation.
    Deng CX; Scott F
    Oncogene; 2000 Feb; 19(8):1059-64. PubMed ID: 10713690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform.
    Cao L; Li W; Kim S; Brodie SG; Deng CX
    Genes Dev; 2003 Jan; 17(2):201-13. PubMed ID: 12533509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice.
    Deng CX
    Mutat Res; 2001 Jun; 477(1-2):183-9. PubMed ID: 11376699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor formation in Brca1 conditional mutant mice.
    Deng CX
    Environ Mol Mutagen; 2002; 39(2-3):171-7. PubMed ID: 11921186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc deficiency potentiates induction and progression of lingual and esophageal tumors in p53-deficient mice.
    Fong LY; Jiang Y; Farber JL
    Carcinogenesis; 2006 Jul; 27(7):1489-96. PubMed ID: 16543248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.
    Moynahan ME
    Oncogene; 2002 Dec; 21(58):8994-9007. PubMed ID: 12483515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.